AbCellera Biologics Inc.: common_shares_outstanding
| Value | {"unit": "shares", "value": 298355752, "concept": "us-gaap:CommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | superseded |
| Entity | AbCellera Biologics Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:26:11.740565+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/981ece15-86df-4216-a6f9-a02aed8086a5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-25-023836Retrieved: 2026-08-19T17:26:11.740565+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001703057/common-shares-outstanding/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/981ece15-86df-4216-a6f9-a02aed8086a5
History
- supersedes {"unit": "shares", "value": 295757002, "concept": "us-gaap:CommonStockSharesOutstanding"} (evidence 0001628280-25-008689)